IMMvention Therapeutix, Inc.
PrivateLast Round
Seed
Jan 10, 2023
Total Funding Raised
$2M
Momentum Score
50 /100
Company Overview
IMMvention Therapeutix, Inc. is a biotechnology company discovering and developing oral novel small molecule first-in-class inhibitors of Bach1 for diseases such as sickle cell disease, renal, cardiometabolic, and neuroinflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IMMvention Therapeutix, Inc. Comps
Public and private peers based on sector, stage, and business model.
IMMvention Therapeutix, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 10, 2023 | ||||
| VC Round | Dec 22, 2020 | ||||
| Debt | Aug 21, 2020 |
Key People
Founding team and executive leadership
IMMvention Therapeutix, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hatteras Venture Partners | Seed, VC Round |
| Osage University Partners | Seed, VC Round |
| Alexandria Venture Investments | Seed |
| North Carolina Biotechnology Center | Seed, Debt |
| Delin Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2026
Grew 27% QoQ, from 11 to 14 employees.
- Apr 20, 2026
Monthly visitors grew 727% MoM, reaching 1.7K.
IMMvention Therapeutix, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IMMvention Therapeutix, Inc.'s valuation, stock price, and market status.
